Mimedx Group Inc (NASDAQ:MDXG) shares, rose in value on Friday, July 11, with the stock price down by -1.77% to the previous day’s close as strong demand from buyers drove the stock to $6.66.
Actively observing the price movement in the last trading, the stock closed the session at $6.78, falling within a range of $6.57 and $6.79. The value of beta (5-year monthly) was 1.8 whereas the PE ratio was 24.69 over 12-month period. Referring to stock’s 52-week performance, its high was $10.14, and the low was $5.47. On the whole, MDXG has fluctuated by 1.99% over the past month.
With the market capitalization of Mimedx Group Inc currently standing at about $983.70 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Apr-30.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that MDXG’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 2.83, with the price of MDXG currently trading nearly 7.22% and 2.05% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 57.43, while the 7-day volatility ratio is showing 4.51% which for the 30-day chart, stands at 3.84%. Furthermore, Mimedx Group Inc (MDXG)’s beta value is 1.78.
A comparison of Mimedx Group Inc (MDXG) with its peers suggests the former has fared considerably weaker in the market. MDXG showed an intraday change of -1.77% in last session, and over the past year, it shrunk by -30.77%%.
Data on historical trading for Mimedx Group Inc (NASDAQ:MDXG) indicates that the trading volumes over the past 10 days have averaged 0.96 and over the past 3 months, they’ve averaged 720.89K. According to company’s latest data on outstanding shares, there are 147.61 million shares outstanding.
Nearly 21.59% of Mimedx Group Inc’s shares belong to company insiders and institutional investors own 50.29% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 5.0 million shares as on 2025-06-13, resulting in a short ratio of 8.93. According to the data, the short interest in Mimedx Group Inc (MDXG) stood at 424.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 5.35 million. The stock has fallen by -2.49% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MDXG stock heading into the next quarter.
